A series of panels convened by the Food and Drug Administration is raising concerns that the agency is skirting federal rules ...

By Sneha S K and Bageshri Banerjee (Reuters) -The U.S. Food and Drug Administration on Thursday approved Ionis ...

The Food and Drug Administration has authorized emergency use of animal drugs to treat and prevent infestations of the New ...

A little boy in the Chicago area is battling a rare disease and desperately needs a drug treatment for a better life. The ...

The initiative is a response to a Trump administration order to speed the construction of the type of new drug factories many ...

The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...

Dawnzera is the third medicine cleared by U.S. regulators this year for the rare genetic condition, and the second wholly owned medicine Ionis has brought to market.

The Food and Drug Administration (FDA) became authorized Tuesday to allow the use of animal drugs to treat or prevent ...

Uagnda's Dei BioPharma Ltd has announced that the U.S. Food and Drug Administration has accepted the development plan for two of its novel biological drugs, liraglutide and semaglutide, which are used ...

Ionis Pharmaceuticals won FDA approval for a drug that prevents painful swelling attacks triggered by a rare genetic ...